These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study. Baron M; Peyronnet B; Aublé A; Hascoet J; Castel-Lacanal E; Miget G; Le Doze S; Prudhomme T; Manunta A; Cornu JN; Gamé X J Urol; 2019 Apr; 201(4):769-776. PubMed ID: 30359679 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial. Abdel-Meguid TA J Urol; 2010 Dec; 184(6):2423-8. PubMed ID: 20952003 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for the management of bladder dysfunction. Schurch B Drugs; 2006; 66(10):1301-18. PubMed ID: 16903766 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic review. Soljanik I Drugs; 2013 Jul; 73(10):1055-66. PubMed ID: 23775527 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin treatment for bladder dysfunction. Santos-Silva A; da Silva CM; Cruz F Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. Herschorn S; Gajewski J; Ethans K; Corcos J; Carlson K; Bailly G; Bard R; Valiquette L; Baverstock R; Carr L; Radomski S J Urol; 2011 Jun; 185(6):2229-35. PubMed ID: 21497851 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Gamé X; Mouracade P; Chartier-Kastler E; Viehweger E; Moog R; Amarenco G; Denys P; De Seze M; Haab F; Karsenty G; Kerdraon J; Perrouin-Verbe B; Ruffion A; Soler JM; Saussine C J Pediatr Urol; 2009 Jun; 5(3):156-64. PubMed ID: 19264554 [TBL] [Abstract][Full Text] [Related]
13. Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder. Ellsworth P; Travis M Urol Nurs; 2014; 34(4):165-71. PubMed ID: 25233617 [TBL] [Abstract][Full Text] [Related]